Advertisement

Topics

Oxxon Pharmaccines Limited Company Profile

17:27 EST 24th November 2017 | BioPortfolio

Oxxon Pharmaccines™ Ltd is a biotechnology company developing novel pharmaccines (therapeutic vaccines) based on its unique PrimeBoost technologies for the treatment of chronic infectious diseases and cancer. We currently have products in clinical trials for the treatment of melanoma and hepatitis B virus, and our founding collaborators have ongoing clinical programmes developing preventative vaccines for malaria and HIV, which are also based on Oxxon's novel PrimeBoost approach.



Unlike conventional vaccines that can only be used to prevent disease, Oxxon's PrimeBoost approach may be used to both prevent and treat disease. We will focus our internal development efforts on innovative products to treat patients with existing disease and use our two-stage treatment regime to greatly enhance the patient's own ability to destroy cancerous or infected cells.



We will collaborate with pharmaceutical and biotechnology companies where opportunities to explore new treatments or preventative vaccines for serious diseases are mutually beneficial, and where complementary technologies may increase the likelihood of success.

Location

Oxford BioBusiness Centre, Littlemoor Park
Littlemoor
Oxfordshire
OX4 4SS
United Kingdom

Contact

Phone: 01865 405 135
Fax: 01865 405 136
Email: info@oxxonpharmaccines.com


News Articles [20 Associated News Articles listed on BioPortfolio]

Oxford BioMedica: Vector Value: An Interview with Nick Woolf, SVP Corporate Strategy

Fintan Walton talks to Nick Woolf, Senior Vice President, Corporate Strategy, Oxford BioMedica, about the company’s ongoing success as it moves toward its ultimate goal of becoming a fully integrate...

Appointment of Director

Oxford, UK, 1 November 2017: e-Therapeutics plc (AIM: ETX), a company pioneering the use of Network-Driven Drug Discovery (NDD) to create new and better drugs, announces the appointment of Christine...

Telix Pharmaceuticals Limited Lists on the Australian Securities Exchange

MELBOURNE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the developmen...

Oncobiologics announces strategic partnership with GMS Tenshi Holdings Pte. Limited

CRANBURY, N.J., Sept. 08, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that it entered into a Purchase Agreement on September 7, 2017 with GMS Tenshi Holdings Pte. Li...

Quotient Limited to Participate in the Jefferies 2017 London Healthcare Conference

JERSEY, Channel Islands, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Execut...

Quotient Limited Reports Second Quarter Fiscal 2018 Financial Results

MosaiQ project de-risked, Verification and Validation (“V&V”) “head-to-head” studies confirm targeted concordance levels for all blood grouping assaysEuropean field trials planned to co...

Quotient Limited to Participate in the Cantor Fitzgerald 2017 Global Healthcare Conference

JERSEY, Channel Islands, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive...

Kevin McCann and Mark Nelson Appointed to the Board of Directors of Telix Pharmaceuticals Limited

MELBOURNE, Australia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) is pleased to announce that Mr. Kevin McCann AM and Dr. Mark Nelson have be...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [83 Associated Companies listed on BioPortfolio]

Oxxon Pharmaccines Limited

Oxxon Pharmaccines™ Ltd is a biotechnology company developing novel pharmaccines (therapeutic vaccines) based on its unique PrimeBoost technologies for the treatment of chronic infectious diseases a...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

SIEMENS CANADA LIMITED

VASUDHA PHARMA CHEM LIMITED

VASUDHA PHARMA CHEM LIMITED (VPCL) is a Company promoted by a team of accomplished technocrats for Bulk Drug industry with a total capital of Rupees 153 million ( US $ 5Million).All the promoters of V...

More Information about "Oxxon Pharmaccines Limited" on BioPortfolio

We have published hundreds of Oxxon Pharmaccines Limited news stories on BioPortfolio along with dozens of Oxxon Pharmaccines Limited Clinical Trials and PubMed Articles about Oxxon Pharmaccines Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oxxon Pharmaccines Limited Companies in our database. You can also find out about relevant Oxxon Pharmaccines Limited Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record